GSK Wraps Up $2.2 Billion Deal to Buy US-based Rapt Therapeutics
Published on 03/03/2026 at 10:57 am EST
MT Newswires
Share
Share
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,144.00 GBX | +0.99% |
|
-1.47% | +17.51% |
| Apr. 16 | European Equities Traded in the US as American Depositary Receipts Declining in Thursday Trading | MT |
| Apr. 15 | London's FTSE 100 ends lower as healthcare weighs; Mideast in focus | RE |
Employees
66,841
Sector
Pharmaceuticals
Trader
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
AA
Sell
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
21.44GBP
Average target price
20.48GBP
Spread / Average Target
-4.45%
Quarterly revenue - Rate of surprise
- Stock Market
- Stock Market News
- GSK Wraps Up $2.2 Billion Deal to Buy US-based Rapt Therapeutics
Select your edition
All financial news and data tailored to specific country editions
